Open original FDA record ↗Recall record
- FDA identifier
- Z-2363-2019
- Company in FDA record
- Abbott Gmbh & Co. KG
- FDA record creation date
- Aug 24, 2019
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Abbott has identified an issue with all on market versions (v2.6.0 and v2.6.1) of Alinity ci series Software where incorrect results may occur after a system Stop due to the Alinity i re use of reaction vessels (RVs). This issue only occurs if the system is transitioned from Processing to Stopped to Idle.
Source facts
- Action
- Abbott sent an Urgent Product Correction Notice by letter dated 06/10/2019. The letter identified the affected product, problem and actions to be taken. Abbott has identified an issue with all onmarket versions of Alinity ciseries Software where reuse of reaction vessels (RVs) may occur after a system Stop. This issue only occurs if the system is transitioned from Processing to Stopped to Idle and has the potential to cause incorrect results.The letter provided a mitigation strategy for the consignee to use until the updated software is available. For questions U.S. Customers contact Customer Service at 18774ABBOTT (available 24 hours a day, 7 days a week). Customers outside the U.S., please contact your local area Customer Service.
- Initiated
- 2019-06-10
- Root cause
- Software in the Use Environment
- Terminated
- 2023-06-14
- Distribution
- Worldwide Distribution - US Nationwide
- Recall number
- Z-2363-2019
- Recall status
- Terminated
- CDRH record ID
- 174125
- FDA record created
- 2019-08-24
- Recall event number
- 83235